mouse anti orov immune ascitic fluid (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
94
Structured Review
ATCC
mouse anti orov immune ascitic fluid
Mouse Anti Orov Immune Ascitic Fluid, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluid/Oropouche+virus+immune+ascitic+fluid/10__1038_slash_s41467___026___77859___5-416-32-37
Average 94 stars, based on 14 article reviews
Mouse Anti Orov Immune Ascitic Fluid, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluid/Oropouche+virus+immune+ascitic+fluid/10__1038_slash_s41467___026___77859___5-416-32-37
Average 94 stars, based on 14 article reviews
mouse anti orov immune ascitic fluid - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Derivative Assay:Article Title: Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study Article Snippet: .. 14 Xen29 was derived from the pleural Article Title: Activation of a passive, mesoporous silica nanoparticle layer through attachment of bacterially-derived carbon-quantum-dots for protection and functional enhancement of probiotics Article Snippet: .. Protection offered by encapsulation towards B. infantis ATCC 15697 against simulated gastric Incubation:Article Title: Computationally-guided multifunctional nanoplatform for enhanced oral delivery and targeted therapy of Helicobacter pylori using herbal bioactives. Article Snippet: Herbal bioactive ingredients offer considerable promise for the eradication of Helicobacter pylori (H. pylori) due to their inherent non-toxicity, cost-effectiveness, and diverse pharmacological activities.. However, their clinical utility is frequently limited by poor oral bioavailability and insufficient accumulation at target sites.. In this study, we fabricated a multifunctional nanoplatform for H. pylori-targeted therapy developed through a computationally guided design strategy. Article Title: Matrine and baicalin inhibit apoptosis induced by Panton-Valentine leukocidin of Staphylococcus aureus in bovine mammary epithelial cells. Article Snippet: The concentration of S. aureus ATCC 49775 was adjusted to 1.0 × 107 cfu/mL, and fresh medium was added at 1:100 with matrine and baicalin, for final concentrations of matrine at 0 (control), 25, 50, or 100 μg/mL and baicalin at 0 (control), 2.5, 5, or 10 μg/mL. .. The solution was then incubated in a rotary shaker at 37°C, at 120 rpm, for 24 h. Total RNA of the bacterial Article Title: Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors Article Snippet: Slides were blocked at room temperature for 1 h with HBS buffer (10 mM HEPES at pH 7.4 with 150 mM NaCl and 5 mM CaCl 2 ) supplemented to contain 0.02% (wt/vol) casein (Pierce) and 1% (wt/vol) bovine serum albumin (BSA) (Sigma). .. Microarrays were overlaid with VLP solution (50 μg/ml was used in most analyses) at room temperature for 1.5 h and fixed with 4% paraformaldehyde (PFA) diluted in high-pressure liquid chromatography (HPLC)-grade water at 4°C for 30 min. VLP binding was detected following incubation with anti-CHIKV E2 antibody (CHK-152 [ ]; 1:300) or ascites Article Title: Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors Article Snippet: Slides were blocked at room temperature (RT) for 1 h with HBS 497 buffer (10 mM HEPES at pH 7.4 with 150 mM NaCl and 5mM CaCl2) supplemented to 498 contain 0.02% (w/v) casein (Pierce) and 1% (w/v) BSA (Sigma). .. Microarrays were 499 overlaid with VLP solution (50 μg/ml used in most analyses) at 4oC for 1.5 h and fixed 500 with 4% paraformaldehyde (PFA) diluted in HPLC-grade water at 4oC for 30 min. VLP 501 binding was detected following incubation with anti-CHIKV E2 antibody (CHK-152 (112); 502 1:300) or ascites Concentration Assay:Article Title: Computationally-guided multifunctional nanoplatform for enhanced oral delivery and targeted therapy of Helicobacter pylori using herbal bioactives. Article Snippet: Herbal bioactive ingredients offer considerable promise for the eradication of Helicobacter pylori (H. pylori) due to their inherent non-toxicity, cost-effectiveness, and diverse pharmacological activities.. However, their clinical utility is frequently limited by poor oral bioavailability and insufficient accumulation at target sites.. In this study, we fabricated a multifunctional nanoplatform for H. pylori-targeted therapy developed through a computationally guided design strategy. High Performance Liquid Chromatography:Article Title: Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors Article Snippet: Slides were blocked at room temperature for 1 h with HBS buffer (10 mM HEPES at pH 7.4 with 150 mM NaCl and 5 mM CaCl 2 ) supplemented to contain 0.02% (wt/vol) casein (Pierce) and 1% (wt/vol) bovine serum albumin (BSA) (Sigma). .. Microarrays were overlaid with VLP solution (50 μg/ml was used in most analyses) at room temperature for 1.5 h and fixed with 4% paraformaldehyde (PFA) diluted in high-pressure liquid chromatography (HPLC)-grade water at 4°C for 30 min. VLP binding was detected following incubation with anti-CHIKV E2 antibody (CHK-152 [ ]; 1:300) or ascites Article Title: Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors Article Snippet: Slides were blocked at room temperature (RT) for 1 h with HBS 497 buffer (10 mM HEPES at pH 7.4 with 150 mM NaCl and 5mM CaCl2) supplemented to 498 contain 0.02% (w/v) casein (Pierce) and 1% (w/v) BSA (Sigma). .. Microarrays were 499 overlaid with VLP solution (50 μg/ml used in most analyses) at 4oC for 1.5 h and fixed 500 with 4% paraformaldehyde (PFA) diluted in HPLC-grade water at 4oC for 30 min. VLP 501 binding was detected following incubation with anti-CHIKV E2 antibody (CHK-152 (112); 502 1:300) or ascites Binding Assay:Article Title: Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors Article Snippet: Slides were blocked at room temperature for 1 h with HBS buffer (10 mM HEPES at pH 7.4 with 150 mM NaCl and 5 mM CaCl 2 ) supplemented to contain 0.02% (wt/vol) casein (Pierce) and 1% (wt/vol) bovine serum albumin (BSA) (Sigma). .. Microarrays were overlaid with VLP solution (50 μg/ml was used in most analyses) at room temperature for 1.5 h and fixed with 4% paraformaldehyde (PFA) diluted in high-pressure liquid chromatography (HPLC)-grade water at 4°C for 30 min. VLP binding was detected following incubation with anti-CHIKV E2 antibody (CHK-152 [ ]; 1:300) or ascites Article Title: Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors Article Snippet: Slides were blocked at room temperature (RT) for 1 h with HBS 497 buffer (10 mM HEPES at pH 7.4 with 150 mM NaCl and 5mM CaCl2) supplemented to 498 contain 0.02% (w/v) casein (Pierce) and 1% (w/v) BSA (Sigma). .. Microarrays were 499 overlaid with VLP solution (50 μg/ml used in most analyses) at 4oC for 1.5 h and fixed 500 with 4% paraformaldehyde (PFA) diluted in HPLC-grade water at 4oC for 30 min. VLP 501 binding was detected following incubation with anti-CHIKV E2 antibody (CHK-152 (112); 502 1:300) or ascites Encapsulation:Article Title: Activation of a passive, mesoporous silica nanoparticle layer through attachment of bacterially-derived carbon-quantum-dots for protection and functional enhancement of probiotics Article Snippet: .. Protection offered by encapsulation towards B. infantis ATCC 15697 against simulated gastric |